Wutah dodolan YoY sajrone 12 wulan kepungkur: senseibio.com (SNSE)

Logo perusahaan publik senseibio.com (SNSE)

The year-over-year revenue dynamics for the last 12 months provided by the GURU.Markets system are based on the validation of the TMAb platform for T-cell stimulation for Sensei Biotherapeutics (SNSE). The value 0.00 serves as the current parameter for this process. Consequently, Sensei Biotherapeutics (SNSE) is developing ImmunoPhage to create anti-cancer vaccines, relying exclusively on its internal pipeline and academic partnerships without engaging in M&A transactions.

Wutah pendapatan YoY sajrone 12 wulan kepungkur Sensei Bio (SNSE): kanggo periode 11.02.2024 - 16.06.2026

Sensei Biotherapeutics (SNSE) - rincian metrik lan laporan keuangan

Ringkesan analitik perusahaan:Sensei Biotherapeutics
Sampel barang Sensei Bio

Sensei Biotherapeutics (SNSE) is optimizing the development of cancer antibodies through AI automation and robotics. This indicator captures the daily change in trailing twelve-month revenue, measuring revenue growth rates in real time. The metric allows investors to assess the business's operational resilience and the impact of currency factors on capital. This analysis helps identify a slowdown in the company's expansion in a timely manner. The dynamics of these processes are clearly reflected in the trend of the LTM sales volume change.

Pesaing Sensei Biotherapeutics (SNSE)

Wutah dodolan YoY (TTM) NantKwest IBRX|IMCR - Wutah dodolan YoY sajrone rolas wulan kepungkur|JANX (januxrx.com) - Wutah dodolan YoY sajrone 12 wulan kepungkur|Arcus Corp (RCUS) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taun lumaku Zymeworks Corp (ZYME)|Wutah pendapatan YoY sajrone 12 wulan kepungkur TNGX|IOVA - Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur IMTX (Immatics Corp)|Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur XNCR|Wutah dodolan YoY (TTM) CMPX (Compass Therapeutics, Inc.)|Dinamika pendapatan YoY sajrone rolas wulan kepungkur REPL|lyell.com - Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku Innate Pharma S.A|Pyxis (PYXS) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Compugen Ltd - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|IOBT (iobiotech.com) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY (TTM) Sutro Biopharma Inc.|Wutah dodolan YoY sajrone rolas wulan kepungkur MiNK Therapeutics (INKT)|HOWL: Wutah dodolan taun lumaku|Immix Biopharma - Wutah pendapatan YoY sajrone 12 wulan kepungkur|ALX Oncology (ALXO) - Wutah pendapatan taun lumaku|CUE: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan taun lumaku PDSB|sonnetbio.com (SONN) - Wutah dodolan YoY sajrone rolas wulan kepungkur|MAIA Biotechnology Inc (MAIA) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY sajrone rolas wulan kepungkur liminatuspharma.com|Wutah dodolan YoY sajrone rolas wulan kepungkur LVTX|Wutah pendapatan YoY sajrone 12 wulan kepungkur NXTC (NextCure, Inc.)|LPTX: Wutah dodolan taun lumaku|Wutah dodolan YoY sajrone rolas wulan kepungkur intensitytherapeutics.com INTS|Wutah pendapatan taunan sajrone rolas wulan kepungkur Theriva Biologics, Inc. (TOVX)|GRTS: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taunan sajrone rolas wulan kepungkur kinetabio.com KA|NEXI (neximmune.com) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taun lumaku Turnstone Biologics Corporation (TSBX)|Wutah pendapatan YoY sajrone 12 wulan kepungkur VCNX|HARP: Dinamika pendapatan YoY sajrone rolas wulan kepungkur